✦ LIBER ✦

Cytotoxicity of the anti-CD22 immunotoxin HA22 (CAT-8015) against paediatric acute lymphoblastic leukaemia

✍ Scribed by Francis Mussai; Dario Campana; Deepa Bhojwani; Maryalice Stetler-Stevenson; Seth M. Steinberg; Alan S. Wayne; Ira Pastan

Book ID: 108676842
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 153 KB
Volume: 150
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2010.08251.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Novel Anti-CD22 Immunotoxin, Moxetumom

A Novel Anti-CD22 Immunotoxin, Moxetumomab Pasudotox (HA22, CAT-8015): Activity in Pediatric Patients with Relapsed Acute Lymphoblastic Leukemia (ALL) After Allogeneic Hematopoietic Stem Cell Transplantation (SCT)

✍ N.N. Shah; D. Bhojwani; L.B. Silverman; J.A. Whitlock; K. Richards; M. Stetler-S 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Phase I Trial of Anti-CD22 Recombinant I

Phase I Trial of Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox (CAT-8015 or HA22) in Patients With Hairy Cell Leukemia

✍ Kreitman, R. J.; Tallman, M. S.; Robak, T.; Coutre, S.; Wilson, W. H.; Stetler-S 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 184 KB

A phase I study of a combination of anti

A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia

✍ John Schindler; Srikanth Gajavelli; Farhad Ravandi; YuMin Shen; Samir Parekh; Ir 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB